Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease

Govorov,Igor; Ekelund,Lena; Chaireti,Roza; Elfvinge,Petra; Holmström,Margareta; Bremme,Katarina; Mints,Miriam

doi:10.3892/etm.2016.3144

Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease

Authors:
- Igor Govorov
- Lena Ekelund
- Roza Chaireti
- Petra Elfvinge
- Margareta Holmström
- Katarina Bremme
- Miriam Mints
View Affiliations

Affiliations: Department of Women's and Children's Health, Karolinska University Hospital, Stockholm 171 76, Sweden, Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm 171 76, Sweden, Coagulation Unit, Department of Medicine, Karolinska University Hospital, Stockholm 171 76, Sweden
Published online on: March 10, 2016 https://doi.org/10.3892/etm.2016.3144
Pages: 1923-1929

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Women with the inherited bleeding disorder von Willebrand's disease (VWD) face gender-specific hemostatic challenges during menstruation. Heavy menstrual bleeding (HMB) can negatively affect their overall life activities and the health-associated quality of life. The purpose of the present study was to investigate whether women with VWD experienced HMB and an impaired health‑associated quality of life. The study subjects were recruited from the Coagulation Unit of Karolinska University Hospital. Information was retrieved from various self‑administered forms and medical records. Of the 30 women (18‑52 years) that were included in the present study, 50% suffered from HMB, although the majority received treatment for HMB. In addition, almost all the included women perceived limitations in the overall life activities due to menstruation. The health-associated quality of life for women with HMB was significantly lower (P<0.10) with regards to ‘bodily pain’ compared with Swedish women of the general population. In conclusion, women with VWD experienced reduced health-associated quality of life as a result of HMB. Therefore, preventing limitations in overall life activities and improving their health-associated quality of life thorough counseling on menstrual bleeding is important for women with VWD.

View Figures

View References

1	Bowman M, Hopman W, Rapson D, Lillicrap D and James P: The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 8:213–216. 2010. View Article : Google Scholar : PubMed/NCBI
2	Castaman G, Eikenboom JC, Bertina RM and Rodeghiero F: Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost. 82:1065–1070. 1999.PubMed/NCBI
3	Rodeghiero F, Castaman G and Dini E: Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 69:454–459. 1987.PubMed/NCBI
4	Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J and Abshire TC: Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr. 123:893–898. 1993. View Article : Google Scholar : PubMed/NCBI
5	James AH: Von Willebrand disease in women: Awareness and diagnosis. Thromb Res. 124(Suppl 1): S7–S10. 2009. View Article : Google Scholar : PubMed/NCBI
6	National Institute for Health and Clinical Excellence: Guidance: Heavy Menstrual Bleeding. National Collaborating Centre for Women's and Children's Health (UK) (London). 2007.
7	Hallberg L, Högdahl AM, Nilsson L and Rybo G: Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 45:320–351. 1966. View Article : Google Scholar : PubMed/NCBI
8	Lukes AS, Kadir RA, Peyvandi F and Kouides PA: Disorders of hemostasis and excessive menstrual bleeding: Prevalence and clinical impact. Fertil Steril. 84:1338–1344. 2005. View Article : Google Scholar : PubMed/NCBI
9	Committee on Adolescent Health Care; Committee on Gynecologic Practice: Committee Opinion No. 580: Von Willebrand disease in women. Obstet Gynecol. 122:1368–1373. 2013. View Article : Google Scholar : PubMed/NCBI
10	Davidson BR, Dipiero CM, Govoni KD, Littleton SS and Neal JL: Abnormal uterine bleeding during the reproductive years. J Midwifery Womens Health. 57:248–254. 2012. View Article : Google Scholar : PubMed/NCBI
11	Lassila R, Holme PA, Landorph A, Petrini P, Onundarson PT and Hillarp A: Nordic haemophilia council's practical guidelines on diagnosis and management of von Willebrand disease. Semin Thromb Hemost. 37:495–502. 2011. View Article : Google Scholar : PubMed/NCBI
12	Kirtava A, Drews C, Lally C, Dilley A and Evatt B: Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: A case-control study. Haemophilia. 9:292–297. 2003. View Article : Google Scholar : PubMed/NCBI
13	Kuzmina N, Palmblad J and Mints M: Predictive factors for the occurrence of idiopathic menorrhagia: Evidence for a hereditary trait. Mol Med Rep. 4:935–939. 2011.PubMed/NCBI
14	Barr RD, Sek J, Horsman J, Furlong W, Saleh M, Pai M and Walker I: Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol. 73:108–114. 2003. View Article : Google Scholar : PubMed/NCBI
15	Côté I, Jacobs P and Cumming D: Work loss associated with increased menstrual loss in the United States. Obstet Gynecol. 100:683–687. 2002. View Article : Google Scholar : PubMed/NCBI
16	Hagstad A: Gynecology and sexuality in middle-aged women. Women Health. 13:57–80. 1988. View Article : Google Scholar : PubMed/NCBI
17	Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, et al: Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 4:2103–2114. 2006. View Article : Google Scholar : PubMed/NCBI
18	Dunn CJ and Goa KL: Tranexamic acid: A review of its use in surgery and other indications. Drugs. 57:1005–1032. 1999. View Article : Google Scholar : PubMed/NCBI
19	Kaufmann JE and Vischer UM: Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost. 1:682–689. 2003. View Article : Google Scholar : PubMed/NCBI
20	Mannucci PM: How I treat patients with von Willebrand disease. Blood. 97:1915–1919. 2001. View Article : Google Scholar : PubMed/NCBI
21	Bahamondes L, Bahamondes MV and Monteiro I: Levonorgestrel-releasing intrauterine system: Uses and controversies. Expert Rev Med Devices. 5:437–445. 2008. View Article : Google Scholar : PubMed/NCBI
22	Lethaby A, Irvine GA and Cameron I: Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev. 2008. View Article : Google Scholar
23	Ruta DA, Garratt AM, Chadha YC, Flett GM, Hall MH and Russell IT: Assessment of patients with menorrhagia: How valid is a structured clinical history as a measure of health status? Qual Life Res. 4:33–40. 1995. View Article : Google Scholar : PubMed/NCBI
24	Coulter A, Peto V and Jenkinson C: Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract. 11:394–401. 1994. View Article : Google Scholar : PubMed/NCBI
25	Higham JM, O'Brien PM and Shaw RW: Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 97:734–739. 1990. View Article : Google Scholar : PubMed/NCBI
26	Sullivan M, Karlsson J, Taft C and Ware JE: SF-36 health survey: Swedish manual and interpretation guide. Sahlgrenska University Hospital. Gothenburg: 2002.(In Swedish).
27	Sullivan M, Karlsson J and Ware JE Jr: The Swedish SF-36 health survey - I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 41:1349–1358. 1995. View Article : Google Scholar : PubMed/NCBI
28	Altman DG: Practical statistics for medical research. Chapman & Hall. London: 1999.
29	Rae C, Furlong W, Horsman J, Pullenayegum E, Demers C, St-Louis J, Lillicrap D and Barr R: Bleeding disorders, menorrhagia and iron deficiency: Impacts on health-related quality of life. Haemophilia. 19:385–391. 2013. View Article : Google Scholar : PubMed/NCBI
30	Byams VR, Kouides PA, Kulkarni R, Baker JR, Brown DL, Gill JC, Grant AM, James AH, Konkle BA, Maahs J, et al: Surveillance of female patients with inherited bleeding disorders in United States haemophilia treatment centres. Haemophilia. 17(Suppl 1): 6–13. 2011. View Article : Google Scholar : PubMed/NCBI
31	Chi C, Huq FY and Kadir RA: Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: Long-term follow-up. Contraception. 83:242–247. 2011. View Article : Google Scholar : PubMed/NCBI
32	Leminen H and Hurskainen R: Tranexamic acid for the treatment of heavy menstrual bleeding: Efficacy and safety. Int J Womens Health. 4:413–421. 2012.PubMed/NCBI
33	Solovieva S: Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia. 7:53–63. 2001. View Article : Google Scholar : PubMed/NCBI
34	de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, et al: Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost. 8:1492–1499. 2010. View Article : Google Scholar : PubMed/NCBI
35	Zakherah MS, Sayed GH, El-Nashar SA and Shaaban MM: Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: Diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest. 71:281–284. 2011. View Article : Google Scholar : PubMed/NCBI
36	Reid PC, Coker A and Coltart R: Assessment of menstrual blood loss using a pictorial chart: A validation study. BJOG. 107:320–322. 2000. View Article : Google Scholar : PubMed/NCBI